<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>0</Volume>
      <Issue>3-4</Issue>
      <PubDate PubStatus="epublish">
        <Year>1977</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Type B Hepatitis in Iran</title>
    <FirstPage>105</FirstPage>
    <LastPage>110</LastPage>
    <AuthorList>
      <Author>
        <FirstName>M.</FirstName>
        <LastName>Tabarestani</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName>J.H.</FirstName>
        <LastName>Hoofnagle</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName>A.</FirstName>
        <LastName>Afkari</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>09</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Hepatitis B surface antigen CHBsAg) was found in 1% of controls, 2.1% of professional blood donors, 2.0% of leprosy patients and 76.1% of acute hepatitis in Tehran and Mashhad, Iran. All HBsAg positive samples also possessed antibody to the hepatitis B core antigen and all were subtype ayw. Type B hepatitis and the HBsAg state aloe frequent in Iran, but most must be accounted for by u nonparenter- al" or "rnapparent'' parenteral exposure.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4212</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4212/4187</pdf_url>
  </Article>
</Articles>
